Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism.

Autor: Gonzalez, Mayra A.1 (AUTHOR), Olivas, Idaly M.1,2 (AUTHOR), Bencomo‐Alvarez, Alfonso E.1 (AUTHOR), Rubio, Andres J.1,3 (AUTHOR), Barreto‐Vargas, Christian4 (AUTHOR), Lopez, Jose L.3 (AUTHOR), Dang, Sara K.2,3 (AUTHOR), Solecki, Jonathan P.2 (AUTHOR), McCall, Emily3 (AUTHOR), Astudillo, Gonzalo3 (AUTHOR), Velazquez, Vanessa V.3 (AUTHOR), Schenkel, Katherine3 (AUTHOR), Reffell, Kelaiah2 (AUTHOR), Perkins, Mariah3 (AUTHOR), Nguyen, Nhu3 (AUTHOR), Apaflo, Jehu N.5 (AUTHOR), Alvidrez, Efren6 (AUTHOR), Young, James E.2 (AUTHOR), Lara, Joshua J.2,3 (AUTHOR), Yan, Dongqing7 (AUTHOR)
Zdroj: Clinical & Translational Medicine. Dec2022, Vol. 12 Issue 12, p1-23. 23p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje